Top Buy
| Security | Buy ▼ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Alnylam Pharmace. | 36 | 0 | 0 | 0 | €141.45 | €236.30 | 67.054% |
| Neurocrine Bioscience | 31 | 0 | 4 | 0 | €125.00 | €140.60 | 12.483% |
| Ultragenyx Pharmaceutical Inc. | 21 | 1 | 5 | 0 | €38.40 | €84.74 | 120.688% |
| United Therapeutics | 20 | 0 | 2 | 0 | €254.50 | €287.40 | 12.928% |
| Halozyme Therapeutics Inc. | 18 | 0 | 4 | 0 | €47.06 | €49.59 | 5.365% |
| Exelixis Inc. | 18 | 0 | 0 | 0 | €20.26 | €26.01 | 28.363% |
| Insulet Corp. | 17 | 0 | 3 | 0 | €177.15 | €216.46 | 22.191% |
| Merit Medical Systems | 17 | 0 | 0 | 0 | €76.50 | €86.90 | 13.591% |
| Arrowhead Pharmaceuticals Inc. | 16 | 2 | 4 | 0 | €22.15 | €54.74 | 147.111% |
| PTC Therapeutics Inc. | 15 | 8 | 2 | 3 | €33.60 | €41.51 | 23.549% |
| Amedisys Inc. | 14 | 0 | 0 | 0 | €83.00 | €92.26 | 11.157% |
| Repligen Corp. | 13 | 0 | 0 | 0 | €134.95 | €184.76 | 36.910% |
| Medpace Holdings Inc | 11 | 0 | 2 | 0 | €371.80 | €419.64 | 12.866% |
| CONMED Corp. | 11 | 1 | 0 | 0 | €71.00 | €106.18 | 49.549% |
| Bio-Techne Corp. | 10 | 0 | 0 | 0 | €72.00 | €75.94 | 5.467% |
| Xencor Inc. | 10 | 1 | 1 | 0 | €20.00 | €32.58 | 62.895% |
| Ensign Group Inc. | 9 | 0 | 0 | 0 | €111.00 | €116.99 | 5.399% |
| Masimo Corp. | 8 | 1 | 1 | 0 | €116.20 | €147.56 | 26.988% |
| Agios Pharmaceuticals Inc. | 7 | 0 | 1 | 0 | €44.20 | €48.75 | 10.293% |
| Amicus Therapeutics Inc. | 7 | 0 | 4 | 0 | €9.65 | €17.64 | 82.774% |
| Myriad Genetics | 5 | 3 | 1 | 1 | €20.60 | €23.08 | 12.026% |
| Nektar Therapeutics | 3 | 1 | 0 | 0 | €1.16 | €3.70 | 218.417% |
| Davita Inc. | 3 | 0 | 1 | 0 | €132.50 | €124.89 | -5.745% |
| Icu Medical Inc. | 3 | 0 | 0 | 0 | €98.50 | €124.85 | 26.749% |
| Healthequity Inc. | 1 | 0 | 0 | 0 | €77.00 | €79.00 | 2.597% |